As per the Drug trend report, the traditional biotech drug that lacks generic competition has been experiencing a continual increase in price. Furthermore, the CMS has reduced the Average Sales Price (ASP) margin from 6% to 4%. All these changes are going to affect the pharmacy reimbursement rate as a consequence. However, there are certainly more aspects due to which pharmaceutics are experiencing their revenues hitting the wall.